Filing Details
- Accession Number:
- 0000950170-24-072420
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-12 16:05:08
- Reporting Period:
- 2024-06-10
- Accepted Time:
- 2024-06-12 16:05:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1937361 | Faye Feller | C/O Geron Corporation 919 E Hillsdale Blvd. Suite 250 Foster City CA 94404 | Evp, Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-10 | 112,500 | $1.06 | 112,500 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-06-10 | 20,000 | $1.06 | 20,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-06-10 | 155,400 | $1.30 | 155,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-10 | 287,900 | $4.63 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 112,500 | $0.00 | 112,500 | $1.06 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 20,000 | $0.00 | 20,000 | $1.06 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 155,400 | $0.00 | 155,400 | $1.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 87,500 | 2032-02-15 | No | 4 | M | Direct | |
| 0 | 2032-02-15 | No | 4 | M | Direct | |
| 0 | 2030-02-11 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022 (of which 112,500 shares were vested as of the exercise date), provided the optionee continues to provide services to the Company.
- Option fully vested.
Billionaire Hedge Funds
